Skip to main content
Advertisement
  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Education
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Online Sections
    • Neurology Video Journal Club
    • Diversity, Equity, & Inclusion (DEI)
    • Innovations in Care Delivery
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • COVID-19
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Null Hypothesis
    • Patient Pages
    • Topics A-Z
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit New Manuscript
    • Submit Revised Manuscript
    • Author Center

Advanced Search

Main menu

  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Education
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Online Sections
    • Neurology Video Journal Club
    • Diversity, Equity, & Inclusion (DEI)
    • Innovations in Care Delivery
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • COVID-19
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Null Hypothesis
    • Patient Pages
    • Topics A-Z
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit New Manuscript
    • Submit Revised Manuscript
    • Author Center
  • Home
  • Articles
  • Issues
  • Blog

User menu

  • My Alerts
  • Log in

Search

  • Advanced search
Neurology: Education
Home
An open access peer-reviewed journal in neurologic and neuroscience training
  • My Alerts
  • Log in
Site Logo
  • Home
  • Articles
  • Issues
  • Blog

Disclosures

Pushpa Narayanaswami, MBBS, DM, FAAN

Scientific Advisory Boards
  1. Commercial entity: Alexion pharmaceuticals 2. Commercial entity: Argenx 3. Commercial entity: Momenta
Funding for travel or speaker honoraria
  Commercial: Alexion Commercial: UCB pharma
Editorial Boards
  1. Neurology. Level of Evidence Review Team 2012- 2. Muscle and Nerve: Associate editor: October 2016- 3. Journal of clinical neuromuscular disease: Member of Editorial Board 2012- 4. Annals of Neurology: Member, editorial Board 2017- 5. MORE, Mc Master Online Rating of Evidence: Reviewer 2018-
Consultancies
  1. Commercial entity: Momenta Pharmaceuticals 2. Commercial entity: Alexion 3. Commercial entity: Argenx 4. Commercial Entity: UCB pharma
Other activities
  Commercial Entity: Blue Cross Blue Shield of MA - Pharmacy and Therapeutics Committee
Research Support, Commercial Entities
  1.Momenta Pharmaceuticals 2. Alexion Pharmaceuticals 3. Ra Pharmaceuticals
Research Support, Government Entities
  1. PCORI, 1609-35953, Co-Primary Investigator, 2017-2021
Neurology: Education: 2 (1)

Articles

  • Articles
  • Issues
  • Popular Articles

About

  • About the Journals
  • Ethics Policies
  • Editors & Editorial Board
  • Contact Us
  • Advertise

Submit

  • Author Center
  • Submit a Manuscript
  • Information for Reviewers
  • AAN Guidelines
  • Permissions

Subscribers

  • Subscribe
  • Sign up for eAlerts
  • RSS Feed
Site Logo
  • Visit neurology Template on Facebook
  • Follow neurology Template on Twitter
  • Visit Neurology on YouTube
  • Neurology
  • Neurology: Clinical Practice
  • Neurology: Education
  • Neurology: Genetics
  • Neurology: Neuroimmunology & Neuroinflammation
  • AAN.com
  • AANnews
  • Continuum
  • Brain & Life
  • Neurology Today

Wolters Kluwer Logo

Neurology: Education | Online ISSN: 2771-9979

© 2023 American Academy of Neurology

  • Privacy Policy
  • Feedback
  • Advertise